Cargando…
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma
Functional impairment of the tumour suppressor PTEN is common in primary prostate cancer and has been linked to relapse post-radiotherapy (post-RT). Pre-clinical modelling supports elevated CXC chemokine signalling as a critical mediator of PTEN-depleted disease progression and therapeutic resistanc...
Autores principales: | Armstrong, Chris W D, Coulter, Jonathan A, Ong, Chee Wee, Maxwell, Pamela J, Walker, Steven, Butterworth, Karl T, Lyubomska, Oksana, Berlingeri, Silvia, Gallagher, Rebecca, O’Sullivan, Joe M, Jain, Suneil, Mills, Ian G, Prise, Kevin M, Bristow, Robert G, LaBonte, Melissa J, Waugh, David J J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380483/ https://www.ncbi.nlm.nih.gov/pubmed/32743555 http://dx.doi.org/10.1093/narcan/zcaa012 |
Ejemplares similares
-
Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor development
por: Park, Vivian S, et al.
Publicado: (2022) -
The HelQ human DNA repair helicase utilizes a PWI-like domain for DNA loading through interaction with RPA, triggering DNA unwinding by the HelQ helicase core
por: Jenkins, Tabitha, et al.
Publicado: (2021) -
Escape from G1 arrest during acute MEK inhibition drives the acquisition of drug resistance
por: Channathodiyil, Prasanna, et al.
Publicado: (2022) -
Dual inhibition of DNA-PK and DNA polymerase theta overcomes radiation resistance induced by p53 deficiency
por: Kumar, Rashmi J, et al.
Publicado: (2020) -
Ku–DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks
por: Mendoza-Munoz, Pamela L, et al.
Publicado: (2023)